Backgrounds/Aims: The diagnosis for cystic neoplasm of pancreas is based on the morphologic criteria through imaging studies, but the pre-and postoperative diagnoses are often inconsistent. This study aims at the analysis of clinical characteristics and the results of surgical treatments. Methods: A retrospective review was performed on 93 patients who have undergone surgery for pancreatic cystic diseases in our hospital from January 2001 to February 2013. Among them, 69 patients were confirmed as cystic neoplasms based on pathologic findings. Their clinical manifestations, diagnostic accuracy, surgical method and complications, pathologic findings were analyzed. Results: Serous cystic neoplasm was the most common (n=22), followed by mucinous cystic neoplasm (n=18), intraductal papillary mucinous tumor (n=11), solid pseudopapillary tumor (n=9), neuroendocrine tumor (n=7), and cystic lymphangioma (n=2). The most common clinical symptom is abdominal pains (49.3%). Preoperative imaging studies were consistent with pathological findings in 72% of patients. Cystic fluid CEA levels of 400 ng/ml or more were reliable to detect mucin secreting tumors. Pancreatoduodenectomy was performed for 13 cases and the remaining 54 patients were treated with left-side pancreatectomy. Malignancy was found in 9 cases (13%) of mucin secreting tumors; 5 cases (27.8%) in mucinous cystic neoplasm and 4 cases (36.4%) in intraductal papillary mucinous tumor. Two of these survived without recurrences during the follow-up periods. 
INTRODUCTION
Cystic neoplasm of pancreas is a rare disease accounting for about 10-15% of cystic disease diagnosed in the pancreas. Among these, malignant cancer accounts for approximately 1% of the entire pancreas malignant cancer and shows significantly different prognosis from pancreatic adenocarcinoma. Since the most common serous cystadenoma and mucinous cystic tumor were identified by Compagno and Oertel, varieties of other forms have been reported. As the cystic neoplasms of pancreas, which does not have obvious clinical symptoms and has a relatively late onset of symptoms, is increasingly discovered owing to the health screening examination, recently. The establishment of the treatment protocol in accordance with the natural history of the tumors has been an emerging issue.
The preoperative diagnosis of patients is based on morphologic criteria through imaging studies, but preoperative and postoperative diagnoses are often inconsistent despite the development of various imaging techniques. Some of the cystic neoplasms of pancreas are precancerous lesion that requires surgical resection and sometimes progress to malignant cancer during follow-up; the prognosis of these patients is known to be relatively poor. Therefore, studies are needed on how to identify each tumor accurately and whether it is benign or malignant.
METHODS
Subjects were 93 patients who have undergone surgery solid pseudopapillary tumor (9), neuroendocrine tumor (7), and cystic lymphangioma (2). The age distribution did not show a statistically significant difference among patient groups, but patient group with solid pseudopapillary tumor showed youngest age than other groups. Unusually, intraductal papillary mucinous tumor occurred more in the males (Table 1) .
RESULTS

Distribution and characteristics of patients
Clinical manifestations
Abdominal pain (49.3%) is the most common clinical symptom. Eighteen patients (26.1%) have been found incidentally through a health screening without any symptoms, and 7 patients (10.1%) had gastrointestinal symptoms such as nausea, vomiting, and dyspepsia. Other 6 patients (8.7%) were diagnosed with cystic neoplasms of pancreas after imaging tests from urinary symptoms such as hematuria or frequent urination (Table 2) .
Location and size of cystic neoplasms
The tumors were found in the pancreatic head (18) and tail (6) . The size of each group showed no statistically significant differences and the average size are being distributed in the range from 5.0 to 7.0 cm ( Table 3 ).
Accuracy of preoperative imaging studies
Most recommended diagnosis of disease through preoperative ultrasound, CT or MRI, and the endoscopic ultrasounds were compared with the final pathologic findings. 72% of the diagnoses were consistent with were finally diagnosed with serous cystic neoplasm. Of the 12 patients who were diagnosed with intraductal papillary mucinous tumor, 10 patients (83%) were consistent with the pathology and 2 patients were diagnosed with serous cystic tumor. The four patients who were suspected of neuroendocrine tumors before surgery were diagnosed the same in pathologic examination after surgery, showing the highest diagnostic accuracy (Table 4) .
Cystic fluid analysis by fine-needle aspiration
Only 
SCN, serous cystic neoplasm; MCN, mucinous cystic neoplasm; IPMN, intraductal papillary mucinous neoplasm; SPT, solid pseudopapillary tumor; NET, neuroendocrine tumor; CL, cystic lymphangioma; PD, pancreatoduodenectomy; PPPD, pylorus preserving pancreatoduodenectomy; LP, left-side pancreatectomy including distal pancreatectomy *Parenthesis, laparoscopic pancreatectomy (18.8%) and intra-abdominal bleeding in 3 cases (4.3%).
There was no case of death from surgical complications.
Comparison of serous cystic neoplasm with mucin-secreting cystic tumors
Clinical features were comparatively analyzed for serous cystic neoplasm, and mucinous cystic neoplasm and intraductal papillary mucinous tumor that are mucin secreting tumors considered as precancerous lesions. The main symptoms and sizes at the time of discovery were not significantly different between each patient group.
Patient group with intraductal papillary mucinous tumor had significantly higher average age than the other two groups (p=0.023). The location of this tumor was characterized that it was mainly found in the pancreatic head and body and none was found in the pancreatic tail area.
The onset of malignant cancer in the two groups with mucin secreting cystic tumor was significantly higher because there was no malignant tumor in serous cystic tumor, 5 cases (27.8%) in mucinous cystic neoplasm and 4 cases (36.4%) in intraductal papillary mucinous tumor (p＜0.001) ( Table 6 ).
Postoperative follow-up and prognosis of patients with malignant tumors (Table 7) .
DISCUSSION
Unlike pancreatic adenocarcinoma, the cystic neo- Inadequate biopsy was often presented as the recurrence factor after surgical resections of mucinous cystadenocarcinoma. 7, 8 Even though the resection tissues were diagnosed as benign or borderline tumors in the past, if recurrences occurred later, it turned out to be insufficient diagnosis for malignant cells of the past biopsy. However, considering that tumor recurrences were not found in patients diagnosed with benign tumors, the prognosis of borderline tumors included herein are expected to be very good. Therefore, the importance of early diagnosis and aggressive surgery are being emphasized once again before proceeding to malignant tumors.
Intraductal papillary mucinous tumor is a disease that gradually increases in numbers among cystic neoplasms of pancreas. It is often difficult to pathologically differentiate from mucinous cystic neoplasms, which is similar in that opinions vary from benign tumors to carcinoma in situ or invasive cancer. Especially when the main pancreatic duct types are known, and that surgery is needed in most cases pursuant to pancreatic adenocarcinoma because malignant cancers are more commonly found in this type. 9, 10 The likelihood of malignancy is higher and requires more attention, for cases such as obstructive jaundice, main pancreatic duct type and hybrid type, where the main pancreatic duct significantly expands more than 10-15 mm, intramural nodules are larger than 10 mm, duct wall irregularities, or tumors are larger than 3 cm.
11,12
Jang et al. 13 reported that careful diagnosis and treatment protocols were required because the incidences of malignant tumors are more than 25% if the tumor size is larger than 2 mm, and there exists the intramural nodule even if it is the branch duct type. In our study, patients diag- However, we did not experience particular complications from preoperative fine needle aspirations and troubles during the surgery. Since the introduction of test equipments, 6 patients were checked by fine needle aspirations and the mucinous cystic neoplasm was predicted when the CEA level of the cystic fluid is over 400 ng/ml or CA19-9 is greater than 40 U/ml. The number of patients was limited, but all four patients whose CEA levels were higher than 400 ng/ml were diagnosed as mucinous cystic neoplasms and showed the specificity of 100%. Thus, it is suggested that to perform both endoscopic ultrasounds and fine needle aspirations for all patients in the future to increase the accuracy of the diagnosis. Researches would be needed for a larger number of patients, but by considering the experiences to date, it is often judged that the serous cystic neoplasm is the primary suspect when the CEA and CA19-9 of the fluids are in the normal range. However, there are still limitations for accurately diagnosing mucinous cystic neoplasms even if these diagnoses are used.
We experienced that two patients who had relatively high CEA and CA19-9 of the fluid were diagnosed with pancreatic pseudocyst and cystic lymphangioma, respectively.
It is recommended on one hand to use a combination of various diagnostic methods for the preoperative diagnosis in order to reduce unnecessary surgery for patients with observable progress, and on the other hand, to prevent the delays in surgery. 17 Despite some controversies, most studies recommended surgical resection in principle for the management of cystic neoplasms of pancreas. The biggest reason is said to be the difficulty of accurate diagnosis on the preoperative tumor pathological form and the difficulty to identify the presence of malignancy. 18, 19 It is also said that the development of surgical techniques has significantly lowered the mortality and complications of pancreatic resections.
In recent years, the increasing application of laparoscopic pancreatic surgery has made surgical treatments more Therefore, large scale prospective studies would be needed for the future applications of laparoscopic surgeries to patients with malignant pancreatic body and tail tumors as well as benign tumors.
